Signalling and the control of skeletal muscle size (Q37734637)

22 August 2017

1 reference

title

Signalling and the control of skeletal muscle size (English)

1 reference

22 August 2017

Anthony Otto

1

1 reference

PubMed ID

20406633

22 August 2017

Ketan Patel

series ordinal

2

1 reference

PubMed ID

20406633

22 August 2017

language of work or name

English

0 references

publication date

18 April 2010

1 reference

Experimental Cell Research

22 August 2017

1 reference

22 August 2017

316

1 reference

22 August 2017

3059-3066

1 reference

22 August 2017

18

1 reference

Role of insulin-like growth factors in embryonic and postnatal growth

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Expression and Splicing of the Insulin‐Like Growth Factor Gene in Rodent Muscle is Associated with Muscle Satellite (stem) Cell Activation following Local Tissue Damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Multiple transcription start sites in the rat insulin-like growth factor-I gene give rise to IGF-I mRNAs that encode different IGF-I precursors and are processed differently in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

New role for serum response factor in postnatal skeletal muscle growth and regeneration via the interleukin 4 and insulin-like growth factor 1 pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Expression and localisation of IGF-binding protein mRNAs in regenerating rat skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

IGF-1, inflammation and stem cells: interactions during muscle regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

p42/p44 mitogen-activated protein kinases activation is required for the insulin-like growth factor-I/insulin induced proliferation, but inhibits differentiation, in rat fetal brown adipocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Skeletal muscle hypertrophy and atrophy signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

GSK-3beta negatively regulates skeletal myotube hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

IGF-I activates the mouse type IIb myosin heavy chain gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

The origin, molecular regulation and therapeutic potential of myogenic stem cell populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

IGF-1 induces human myotube hypertrophy by increasing cell recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Regulation of myostatin activity and muscle growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Skeletal muscle cell hypertrophy induced by inhibitors of metalloproteases; myostatin as a potential mediator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

The regulation and action of myostatin as a negative regulator of muscle development during avian embryogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Regulation of muscle mass by myostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Morphology and myofiber composition of skeletal musculature of the forelimb in young and aged wild type and myostatin null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Induction of cachexia in mice by systemically administered myostatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Multiple defects and perinatal death in mice deficient in follistatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin imposes reversible quiescence on embryonic muscle precursors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin promotes the terminal differentiation of embryonic muscle progenitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Functional improvement of dystrophic muscle by myostatin blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Administration of a mutated myostatin propeptide to neonatal mice significantly enhances skeletal muscle growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Inhibition of myostatin in adult mice increases skeletal muscle mass and strength

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin negatively regulates satellite cell activation and self-renewal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.009

10.1016/J.YEXCR.2010.04.009

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20406633